ATNM
Price
$1.78
Change
+$0.06 (+3.49%)
Updated
Sep 6 closing price
47 days until earnings call
QNRX
Price
$0.77
Change
-$0.03 (-3.75%)
Updated
Sep 6 closing price
Ad is loading...

ATNM vs QNRX

Header iconATNM vs QNRX Comparison
Open Charts ATNM vs QNRXBanner chart's image
Actinium Pharmaceuticals
Price$1.78
Change+$0.06 (+3.49%)
Volume$334.18K
CapitalizationN/A
Quoin Pharmaceuticals
Price$0.77
Change-$0.03 (-3.75%)
Volume$62.27K
CapitalizationN/A
View a ticker or compare two or three
ATNM vs QNRX Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ATNM vs. QNRX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Sell and QNRX is a Buy.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (ATNM: $1.78 vs. QNRX: $0.77)
Brand notoriety: ATNM and QNRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 33% vs. QNRX: 102%
Market capitalization -- ATNM: $55.45M vs. QNRX: $3.06M
ATNM [@Biotechnology] is valued at $55.45M. QNRX’s [@Biotechnology] market capitalization is $3.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileQNRX’s FA Score has 2 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • QNRX’s FA Score: 2 green, 3 red.
According to our system of comparison, QNRX is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while QNRX’s TA Score has 5 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 3 bearish.
  • QNRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than QNRX.

Price Growth

ATNM (@Biotechnology) experienced а -10.55% price change this week, while QNRX (@Biotechnology) price change was +22.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

ATNM is expected to report earnings on Oct 25, 2024.

QNRX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($55.5M) has a higher market cap than QNRX($3.06M). ATNM YTD gains are higher at: -64.961 vs. QNRX (-84.306). QNRX has higher annual earnings (EBITDA): -8.14M vs. ATNM (-45.91M). ATNM has more cash in the bank: 86M vs. QNRX (12.6M). ATNM has less debt than QNRX: ATNM (1.85M) vs QNRX (6.21M). ATNM has higher revenues than QNRX: ATNM (81K) vs QNRX (0).
ATNMQNRXATNM / QNRX
Capitalization55.5M3.06M1,811%
EBITDA-45.91M-8.14M564%
Gain YTD-64.961-84.30677%
P/E RatioN/AN/A-
Revenue81K0-
Total Cash86M12.6M683%
Total Debt1.85M6.21M30%
FUNDAMENTALS RATINGS
ATNM vs QNRX: Fundamental Ratings
ATNM
QNRX
OUTLOOK RATING
1..100
753
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9655
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNRX's Valuation (14) in the Biotechnology industry is somewhat better than the same rating for ATNM (77). This means that QNRX’s stock grew somewhat faster than ATNM’s over the last 12 months.

QNRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that QNRX’s stock grew similarly to ATNM’s over the last 12 months.

QNRX's SMR Rating (98) in the Biotechnology industry is in the same range as ATNM (98). This means that QNRX’s stock grew similarly to ATNM’s over the last 12 months.

QNRX's Price Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for ATNM (96). This means that QNRX’s stock grew somewhat faster than ATNM’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATNM (100). This means that QNRX’s stock grew significantly faster than ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMQNRX
RSI
ODDS (%)
Bullish Trend 5 days ago
69%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHDN136.68-1.88
-1.36%
Churchill Downs
FRD14.47-0.28
-1.90%
Friedman Industries
MPLN0.24-0.01
-2.40%
MultiPlan Corp
XPRO17.72-0.58
-3.17%
Expro Group Holdings NV
KAVL0.59-0.04
-5.99%
Kaival Brands Innovations Group

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with LOGC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+3.49%
LOGC - ATNM
43%
Loosely correlated
-0.38%
XNCR - ATNM
40%
Loosely correlated
-0.86%
NVIVQ - ATNM
38%
Loosely correlated
N/A
GBIO - ATNM
38%
Loosely correlated
-6.03%
NTLA - ATNM
37%
Loosely correlated
-5.78%
More

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with PSTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then PSTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-3.45%
PSTX - QNRX
47%
Loosely correlated
+1.11%
ATNM - QNRX
35%
Loosely correlated
+3.49%
MRNA - QNRX
28%
Poorly correlated
-0.75%
EYEN - QNRX
28%
Poorly correlated
-3.67%
HSTO - QNRX
27%
Poorly correlated
N/A
More